The use of sacubitril/valsartan appears feasible and safe in recipients of left ventricular assist devices, reducing the need ...
Pfizer's stock has been trading at low levels for a while. Diminished growth and concerns about the future have investors ...
Bristol Myers Squibb has a 5.6% yield and has been building its drug pipeline with acquisitions. Merck has a 3.7% yield and a ...
Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...
Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...
Money Talks News on MSN
Pfizer's 2025 COVID Vaccine Boosts Immunity 4x, Access Severely Limited Nationwide
Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...
President Donald Trump’s new partnership with Pfizer to sell drugs directly to consumers is being cast as a major ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting an observational cohort study titled ‘Treating ...
U.S. Investment Forum 2025, a renowned era that has significantly unfolded the relationship between the Kingdom of Saudi ...
Shares of Novartis fell 1% on Monday following news of the company's plans to acquire U.S. biotech Avidity Biosciences for ...
Dubai: Pfizer Saudi Arabia and Lifera, a Public Investment Fund (PIF) company, have signed a Memorandum of Understanding (MoU) to explore local manufacturing opportunities for pharmaceuticals in Saudi ...
The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results